US Stock MarketDetailed Quotes

KROS Keros Therapeutics

Watchlist

10.860
+0.340+3.23%

Close Jan 17 16:00 ET

11.060
+0.200+1.84%

Post 20:01 ET

439.91MMarket Cap-2.08P/E (TTM)

Keros Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Keros Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 22.233M	--
--	2024/Q4	-- / 37.318M	--
--	2024/Q3	388.000K / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	83.000K / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 22.233M--

--2024/Q4-- / 37.318M--

--2024/Q3388.000K / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q183.000K / 0.000--

Unlock Free Earnings Estimates

Open Account

Keros Therapeutics Earnings Reports

Keros Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 16:30 ET

Keros Therapeutics | 8-K: Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results

Nov 6, 2024 16:10 ET

Keros Therapeutics | 8-K: Keros Therapeutics Reports Second Quarter 2024 Financial Results

Aug 7, 2024 16:09 ET

Keros Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 7, 2024 16:07 ET

Analyst Rating

Updated: Jan 18, 2025

Buy

Buy
68.75%
Hold
31.25%
Sell
0.00%

Price Target

No Data

Heat List

Overall